Response to: Monoclonal antibodies targeting CD20
Main Authors: | Klein, Christian, Lammens, Alfred, Schäfer, Wolfgang, Georges, Guy, Schwaiger, Manfred, Mössner, Ekkehard, Hopfner, Karl-Peter, Umaña, Pablo, Niederfellner, Gerhard |
---|---|
Format: | Online |
Language: | English |
Published: |
Landes Bioscience
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169027/ |
Similar Items
-
Monoclonal antibodies targeting CD20
by: Chang, Chien-Hsing, et al.
Published: (2013) -
Novel CD20 monoclonal antibodies for lymphoma therapy
by: Cang, Shundong, et al.
Published: (2012) -
Ofatumumab: a novel monoclonal anti-CD20 antibody
by: Lin, Thomas S
Published: (2010) -
Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding
by: Lammens, Alfred, et al.
Published: (2013) -
Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma
by: Herting, Frank, et al.
Published: (2014)